JENNIFER HAMILTON: Open Payments
NPI 1215376124 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$32,670 in 197 payments from 23 companies in 2025. Trend: 2023 $1,642 · 2024 $15,091 · 2025 $32,670
Speaker / faculty: $20,601Travel & lodging: $6,455Food & beverage: $5,531Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 64 | $24,197 |
| Phathom Pharmaceuticals, Inc. | 15 | $4,415 |
| Merck Sharp & Dohme LLC | 8 | $1,171 |
| Madrigal Pharmaceuticals | 18 | $890 |
| ABBVIE INC. | 38 | $696 |
| PFIZER INC. | 11 | $212 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $180 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Intercept Pharmaceuticals, Inc. | 3 | $77 |
| Celltrion USA Inc. | 4 | $74 |
Products named: TREMFYA, VOQUEZNA, REZDIFFRA, STELARA, CREON, SKYRIZI, XIFAXAN, RINVOQ.
Industry payments across MD — which companies pay providers there.
